Effect of Training on Brain Volume in Ataxia

Status Completed

Clinical Trial Summary

The primary aim is to show balance training improves DCD individual's ability to compensate for their activity limitations, but does not impact disease progression. The second aim is to demonstrate aerobic exercise improves balance and gait in DCD persons by affecting brain processes and slowing cerebellar atrophy.

Clinical Trial Description

Individuals with degenerative cerebellar disease (DCD) exhibit gradual loss of coordination resulting in impaired balance, gait deviations, and severe, progressive disability. With no available disease-modifying medications, balance training is the primary treatment option to improve motor skills and functional performance. There is no evidence, however, that balance training impacts DCD at the tissue level. Aerobic training, on the other hand, may modify DCD progression as evident from animal data. Compared to sedentary controls, aerobically trained DCD rats have enhanced lifespan, motor function, and cerebellar Purkinje cell survival. Numerous animal studies also document that aerobic training has a direct, favorable effect on the brain that includes production of neurotrophic hormones, enhancement of neuroplasticity mechanisms, and protection from neurotoxins. The effects of aerobic training in humans with DCD are relatively unknown, despite these encouraging animal data. A single study to date has evaluated the benefits of aerobic exercise on DCD in humans, and this was a secondary outcome of the study. Although participants performed limited aerobic training during the study, modest functional benefits were still detected. The main objective of this project will be to compare the benefits of aerobic versus balance training in DCD. We hypothesize that both aerobic and balance training will improve function in DCD subjects, but that the mechanisms in which these improvements occur differ. 1) Balance training improves DCD individual's ability to compensate for their activity limitations, but does not impact disease progression. 2) Aerobic exercise improves balance and gait in DCD persons by impacting the cerebellum ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04837027
Study type	Interventional
Source	Columbia University
Contact
Status	Completed
Phase	N/A
Start date	September 1, 2021
Completion date	March 16, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05973019` - rTMS Improves Functions in Spinocerebellar Ataxia	N/A
Completed	`NCT04595578` - Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia	N/A
Completed	`NCT03745248` - Aerobic Exercise, Balance Training, and Ataxia	N/A
Completed	`NCT05951010` - Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38	N/A
Completed	`NCT01037777` - RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
Completed	`NCT00136630` - Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Completed	`NCT03687190` - Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia Patients	N/A
Active, not recruiting	`NCT03701399` - Troriluzole in Adult Subjects With Spinocerebellar Ataxia	Phase 3
Completed	`NCT05436262` - Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia	N/A
Recruiting	`NCT04231487` - Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
Withdrawn	`NCT04301284` - Study of CAD-1883 for Spinocerebellar Ataxia	Phase 2
Not yet recruiting	`NCT06177626` - Impact of Exercise on Eyeblink Conditioning in Spinocerebellar Ataxias	N/A
Recruiting	`NCT04529252` - Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
Completed	`NCT05621200` - Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia	N/A
Completed	`NCT03701776` - Ataxia and Exercise Disease Using MRI and Gait Analysis	N/A
Completed	`NCT03120013` - Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia	N/A
Active, not recruiting	`NCT03408080` - Open Pilot Trial of BHV-4157	Phase 3
Active, not recruiting	`NCT02960893` - Trial in Adult Subjects With Spinocerebellar Ataxia	Phase 2/Phase 3
Completed	`NCT04153110` - Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia	N/A
Recruiting	`NCT05034172` - Biomarker Research in Inherited Movement Disorders

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.